facial dystonia Hemifacial spasm Blepharospasm Telemedicine Facial dystonia Blepharospasm Hemifacial spasm Botulinum toxin Telemedicine Reliability Usability Satisfaction
Conditions
Interventions
Examination in-person at the clinic,Examination via telemedicine
No Intervention Other,Experimental Other
In-person group,Telemedicine group
Sponsors
King Chulalongkorn Memorial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age of at least 18 years old, 2. A diagnosis of facial dystonia including blepharospasm and hemifacial spasm, 3. Potential to communicate through Chulalongkorn hospital telemedicine application either by themselves or with helps from their caregivers
Exclusion criteria
Exclusion criteria: 1. Neuromuscular diseases that could affect the results of the study including myasthenia gravis which produces clinical fluctuation related to time, 2. Inability to communicate through telemedicine such as severe dementia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Spasm severity and frequency of facial dystonia 6 months Jankovic Rating Scale | — |
Secondary
| Measure | Time frame |
|---|---|
| Signs of complications after botulinum toxin injection 6 months present/absent,Symptoms of complications after botulinum toxin injection 6 months present/absent,Telemedicine usability 6 months Telehealth usability questionnaire ,Data on the decision for further botulinum toxin injection 3 months indicate/not indicate | — |
Countries
Thailand
Contacts
Public ContactParima Hirunwiwatkul
Faculty of Medicine, Chulalongkorn University
Outcome results
None listed